These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28980408)

  • 21. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
    Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
    Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction.
    Nakada Y; Kawakami R; Nakano T; Takitsume A; Nakagawa H; Ueda T; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Okura H; Saito Y
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(7):H813-20. PubMed ID: 26747499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
    Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic significance of serum galectin-3 levels in heart failure with preserved ejection fraction.
    Polat V; Bozcali E; Uygun T; Opan S; Karakaya O
    Acta Cardiol; 2016 Apr; 71(2):191-7. PubMed ID: 27090041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life questionnaire predicts poor exercise capacity only in HFpEF and not in HFrEF.
    Ahmeti A; Henein MY; Ibrahimi P; Elezi S; Haliti E; Poniku A; Batalli A; Bajraktari G
    BMC Cardiovasc Disord; 2017 Oct; 17(1):268. PubMed ID: 29041912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel echocardiographic hemodynamic classification of heart failure based on stroke volume index and left atrial pressure.
    Abbas AE; Khoury Abdulla R; Aggrawal A; Crile J; Lester SJ; Boura J
    Echocardiography; 2017 Oct; 34(10):1417-1425. PubMed ID: 28833458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Congestion by Lung Ultrasound in Ambulatory Patients With Heart Failure With Reduced or Preserved Ejection Fraction and Hypertension.
    Dwyer KH; Merz AA; Lewis EF; Claggett BL; Crousillat DR; Lau ES; Silverman MB; Peck J; Rivero J; Cheng S; Platz E
    J Card Fail; 2018 Apr; 24(4):219-226. PubMed ID: 29499322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of the ultrasonic determination of the degree of interstitial edema in patients with intermediate ejection fraction of the left ventricle after treating acute decompensation of heart failure].
    Skorodumova EG; Kostenko VA; Skorodumova EA; Siverina AV; Rysev AV; Gayvoronskiy IV; Ilina VA; Shulenin KS; Gayvoronskiy IN
    Kardiologiia; 2020 Nov; 60(10):80-85. PubMed ID: 33228510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
    Lok DJ; Klip IT; Voors AA; Lok SI; Bruggink-André de la Porte PW; Hillege HL; Jaarsma T; van Veldhuisen DJ; van der Meer P
    Eur J Heart Fail; 2014 Sep; 16(9):958-66. PubMed ID: 25082741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin.
    Faxén UL; Hage C; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
    Int J Cardiol; 2017 Feb; 228():709-716. PubMed ID: 27886615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study.
    Carlsen CM; Bay M; Kirk V; Gøtze JP; Køber L; Nielsen OW
    Eur J Heart Fail; 2012 Mar; 14(3):240-7. PubMed ID: 22315457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial dysfunction relates to symptom onset in patients with heart failure and preserved left ventricular ejection fraction.
    Sanchis L; Gabrielli L; Andrea R; Falces C; Duchateau N; Perez-Villa F; Bijnens B; Sitges M
    Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):62-7. PubMed ID: 25187609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction in Middle-Aged Maintenance Haemodialysis Patients on a Twice-Weekly Schedule: Experience from a Single Indian Centre.
    Mathew GG; Pandurangan N; Muthuperumal P; Jayaprakash V
    G Ital Nefrol; 2024 Jun; 41(3):. PubMed ID: 38943322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.